FirstTake on Pharma - Pharma News and Analysis Podcast podkast

The FirstTake Podcast – More questions than answers for Sage and Biogen

Do tyłu o 15 sekund
Do przodu o 15 sekund
FirstWord Pharma PLUS editors Virginia Li and Simon King discuss Phase III clinical data for a new depression therapy being co-developed by Sage Therapeutics and Biogen, the FDA’s new - but also old – commissioner, Robert Califf, whose reappointment five years after he first held the role was confirmed by the US senate this week and whether Regeneron can make its multi-billion dollar eye-disorder therapy Eylea an even more compelling product for physicians.

Więcej odcinków z kanału "FirstTake on Pharma - Pharma News and Analysis Podcast"